ID: ALA3828630

Max Phase: Preclinical

Molecular Formula: C17H12N2O5

Molecular Weight: 324.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C=C/C(=O)Nc1ccc2c(c1)Cc1cc([N+](=O)[O-])ccc1-2

Standard InChI:  InChI=1S/C17H12N2O5/c20-16(5-6-17(21)22)18-12-1-3-14-10(8-12)7-11-9-13(19(23)24)2-4-15(11)14/h1-6,8-9H,7H2,(H,18,20)(H,21,22)/b6-5+

Standard InChI Key:  UWWANAPPEOJEGH-AATRIKPKSA-N

Associated Targets(non-human)

Botulinum neurotoxin type E 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.29Molecular Weight (Monoisotopic): 324.0746AlogP: 2.75#Rotatable Bonds: 4
Polar Surface Area: 109.54Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.44CX Basic pKa: CX LogP: 3.10CX LogD: -0.29
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.44Np Likeness Score: -0.95

References

1. Kumar G, Agarwal R, Swaminathan S..  (2016)  Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model.,  24  (18): [PMID:27353886] [10.1016/j.bmc.2016.06.036]

Source